Inferra AIResearch Tools

Inferra AI / Company / DRS

Leonardo Drs, Inc.

DRS · Industrials

Last earnings Oct 29, 2026

Key results

Revenuequarter

11%

CEO Commentary Leonardo DRS delivered a strong third quarter, with 11% organic revenue growth and profitability growing even faster.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

1 The company reported 11% revenue growth in the third quarter 2026.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Free cash flowquarter

$61 million

The company s free cash flow generation was $61 million in the quarter.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

AI analysis

Q3 2026 · reported Oct 29, 2026

Based on: Earnings release + parent 8-K — transcript not held

Free cash flow · Q3 2026
$61M
EX-99 · Oct 29, 2026

Headline figures

MetricQ3 2026Prior qtrYear ago
Revenue11%10%—
Free cash flow$61 million$6 million—

EX-99 · Oct 29, 2026

Guidance · company-stated

Direction: Raised

Revenue

“6 billion, up 21% year-over-year Raises 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS Dividend Company declares cash dividend of $0.”

Revenue$3,950 million

“3 2026 Guidance Leonardo DRS is increasing 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS based on strong year-to-date performance, as specified in the table below Measure Current 2026 Guidance Prior 2026 Guidance Revenue $3,950 million - $3,985 million $3,900 million - $3,975 million Adjusted EBITDA $545 million - $555 million $525 million - $540 million Tax Rate 13.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Cash flow & capex

Free cash flow$61M

Capital allocation

Revenue$1.1B
Net income11%
Growthup 60%
EPS27%
Dividend$24M

htm EX-99.1 Document Leonardo DRS Announces Financial Results for Third Quarter 2026 Revenue $1.1 billion, up 11% year-over-year Net Earnings $115 million, up 60% year-over-year Adjusted EBITDA $149 million, up 27% year-over-year Diluted EPS $0.43, up 65% year-over-year Adjusted Diluted EPS $0.46, up 59% year-over-year Bookings $1.6 billion (book-to-bill ratio of 1.5x) Record Funded Backlog $5.6 billion, up 21% year-over-year Raises 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS Dividend Company declares cash dividend of $0.09 per share to be paid on November 25, 2026 ARLINGTON, Va.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

These results reinforce a strategy that is working investing ahead of demand, in both differentiated capability and capacity, to help our customers maintain overmatch and enable us to scale when the mission requires it

Based on: Earnings release + parent 8-K — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “6 billion, up 21% year-over-year Raises 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS Dividend Company declares cash dividend of $0.”

Revenue: “3 2026 Guidance Leonardo DRS is increasing 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS based on strong year-to-date performance, as specified in the table below Measure Current 2026 Guidance Prior 2026 Guidance Revenue $3,950 million - $3,985 million $3,900 million - $3,975 million Adjusted EBITDA $545 million - $555 million $525 million - $540 million Tax Rate 13.”

Revenue — Raised (“Raises”)
“6 billion, up 21% year-over-year Raises 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS Dividend Company declares cash dividend of $0.”

Revenue — Raised (“raise”)
“Our record funded backlog, together with improved visibility into the fourth quarter, gives us confidence to raise and narrow our full-year revenue and profitability outlook, said John Baylouny, President and CEO of Leonardo DRS.”

Revenue — Raised (“increasing”)
“3 2026 Guidance Leonardo DRS is increasing 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS based on strong year-to-date performance, as specified in the table below Measure Current 2026 Guidance Prior 2026 Guidance Revenue $3,950 million - $3,985 million $3,900 million - $3,975 million Adjusted EBITDA $545 million - $555 million $525 million - $540 million Tax Rate 13.”

Classified from the release's primary full-year outlook statement.

Capital allocation

htm EX-99.1 Document Leonardo DRS Announces Financial Results for Third Quarter 2026 Revenue $1.1 billion, up 11% year-over-year Net Earnings $115 million, up 60% year-over-year Adjusted EBITDA $149 million, up 27% year-over-year Diluted EPS $0.43, up 65% year-over-year Adjusted Diluted EPS $0.46, up 59% year-over-year Bookings $1.6 billion (book-to-bill ratio of 1.5x) Record Funded Backlog $5.6 billion, up 21% year-over-year Raises 2026 guidance for Revenue, Adjusted EBITDA and Adjusted Diluted EPS Dividend Company declares cash dividend of $0.09 per share to be paid on November 25, 2026 ARLINGTON, Va.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Dividends and Stock Repurchases During the third quarter, dividends paid to stockholders totaled approximately $24 million or $0.09 per share of common stock.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Today, Leonardo DRS announced that its Board of Directors declared a cash dividend of $0.09 per share of common stock payable on November 25, 2026, to stockholders of record on November 12, 2026.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

In addition, the company repurchased 288,633 shares of its common stock for approximately $12 million in the third quarter, pursuant to a previously announced stock repurchase program.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Balance Sheet At the end of the third quarter, the company held $294 million of cash and had no outstanding borrowings under its credit facility.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Department of War ( DoW ) the effect of inflation and other cost pressures on our supply chain and or our labor costs our mix of fixed-price, cost-plus and time-and-materials type contracts and any resulting impact on our cash flows due to cost overruns failure to properly comply with various covenants of the agreements governing our debt could negatively impact our business our dependence on U.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Strategy & priorities

These results reinforce a strategy that is working investing ahead of demand, in both differentiated capability and capacity, to help our customers maintain overmatch and enable us to scale when the mission requires it.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Rigorous program execution across the portfolio, favorable mix and operating leverage of greater volume drove meaningful Adjusted EBITDA growth and margin expansion.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Our reputation as a trusted provider is built on a continuous focus on practical innovation, delivering quality, and meeting our customers most demanding mission requirements.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

government priorities and spending levels more broadly any failure to comply with the amended and restated proxy agreement with the U.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Risks & headwinds

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Other risks, uncertainties and factors, including those discussed in our SEC filings under Risk Factors of our latest Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the investor relations section of our website at www.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Readers should read the discussion of these factors carefully to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

What changed vs prior quarter

Guidance direction — prior quarter: Raised; this quarter: Raised

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Revenue — prior quarter passage and this quarter's passage are both cited.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Free cash flow — prior quarter passage and this quarter's passage are both cited.

SEC original ↗Leonardo Drs, Inc. — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

RELX (RELX) IndustrialsThomson Reuters (TRI) IndustrialsFedEx (FDX) IndustrialsVertiv (VRT) IndustrialsCanadian National Railway (CNI) IndustrialsAerCap Holdings (AER) IndustrialsCanadian Pacific Kansas City (CP) IndustrialsGeneral Dynamics (GD) Industrials
Documents

Filings

32 documents

Earnings releases

12 documents

Presentations

0 documents

No presentations for Leonardo Drs, Inc. are held in this edition of the library.

Transcripts

0 documents

No transcripts for Leonardo Drs, Inc. are held in this edition of the library.

Mentioned by

3 companies

Other tracked companies whose held documents mention Leonardo Drs, Inc. by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.